PlainRecalls
FDA Devices Moderate Class II Terminated

Synergy XVI The Elekta Synergy S is intended to be used for radiation therapy treatment of malignant neoplastic diseases, as determined by a licensed medical practitioner.

Reported: February 26, 2014 Initiated: November 25, 2013 #Z-1061-2014

Product Description

Synergy XVI The Elekta Synergy S is intended to be used for radiation therapy treatment of malignant neoplastic diseases, as determined by a licensed medical practitioner.

Reason for Recall

Potential collision risk when using XVI and external beam shaping devices.

Details

Recalling Firm
Elekta, Inc.
Units Affected
312
Distribution
Worldwide Distribution: US (nationwide) including Puerto Rico and the states of: AL, AK, AZ, CA, CO, CT, FL, GA, IL, IA, KY, MD, MA, MI, MN, MS, MT, NE, NV, NJ, NM, NY, NC, OH, OK, OR, PA, SC, TN, TX, VT, VA, WA, WV, WI, DC, and Internationally to: Algeria, Australia, Austria, Belarus, Belgium, Brazil, Canada, Chile, China, Cyprus, Czech Republic, France, Germany, Greece, Hong Kong, India, Israel, Italy, Japan, Malaysia, Mexico, Pakistan, Portugal, Russia, Singapore, Slovakia, South Korea, Spain, Taiwan, Thailand, and United Kingdom.
Location
Atlanta, GA

Frequently Asked Questions

What product was recalled?
Synergy XVI The Elekta Synergy S is intended to be used for radiation therapy treatment of malignant neoplastic diseases, as determined by a licensed medical practitioner.. Recalled by Elekta, Inc.. Units affected: 312.
Why was this product recalled?
Potential collision risk when using XVI and external beam shaping devices.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 26, 2014. Severity: Moderate. Recall number: Z-1061-2014.